文献速递区域麻醉与超声疼痛医学

全膝关节置换术后腘丛阻滞10 mL与20 mL布比卡因镇痛效果与功能结局的随机临床试验

Analgesic efficacy and functional outcomes of 10 versus 20 mL bupivacaine for popliteal plexus block after total knee arthroplasty: a randomized clinical trial.
PubMed 文献 · Reg Anesth Pain Med · 2026-03-18

该单中心盲法随机对照试验纳入120例椎管内麻醉下初次单侧全膝关节置换术成人,比较腘丛阻滞使用10 mL或20 mL布比卡因(5 mg/mL)的镇痛效果。主要结局为术后24小时阿片类药物消耗量,两组中位数均为15 mg口服吗啡当量(中位差0 mg,95%CI -10至5;p=0.6),无统计学或临床显著差异,支持临床使用10 mL。

要点

  • 腘丛阻滞10 mL与20 mL布比卡因在全膝关节置换术后24小时阿片消耗无显著差异。
  • 两组在无阿片镇痛比例、疼痛评分、早期功能结局及恢复质量上均无显著差异。
  • 基于最低有效剂量原则,临床推荐腘丛阻滞使用10 mL布比卡因。

核心结论

  • 全膝关节置换术后多模式镇痛中,腘丛阻滞使用20 mL布比卡因相比10 mL并未提供更优的镇痛效果或功能结局。
  • 研究结果支持临床实践和未来研究中腘丛阻滞使用10 mL布比卡因,符合最低有效剂量和减少局麻药累积暴露的原则。

研究设计与样本

  • 单中心、盲法、随机对照试验,纳入120例在脊髓麻醉下接受初次单侧全膝关节置换术的成人。
  • 患者随机接受10 mL或20 mL布比卡因(5 mg/mL)的腘丛阻滞,并联合包括股三角阻滞的标准化多模式镇痛方案。

主要发现

  • 术后24小时阿片类药物消耗量(口服吗啡毫克当量)中位数两组均为15 mg(IQR 10mL组3.75-30,20mL组0-30),中位差0 mg(95%CI -10至5;p=0.6)。
  • 两组在实现无阿片镇痛的患者比例、静息或行走时疼痛评分、拄拐行走能力、运动障碍及患者报告的恢复质量-15方面均无统计学显著或临床相关差异。

临床怎么用

  • 在全膝关节置换术多模式镇痛方案中,腘丛阻滞可选择10 mL布比卡因(5 mg/mL),以降低局麻药累积暴露。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: The popliteal plexus block is a motor-sparing regional anesthetic technique used as an adjunct to multimodal analgesia after total knee arthroplasty. Clinical studies have used varying local anesthetic volumes for the block, reflecting uncertainty regarding the optimal volume. This randomized clinical trial aimed to determine whether using 20 mL of local anesthetic for the popliteal plexus block provides superior analgesic efficacy and early functional outcomes compared with 10 mL after total knee arthroplasty. METHODS: In this single-center, blinded, randomized controlled trial, 120 adults undergoing primary unilateral total knee arthroplasty under spinal anesthesia were randomized to receive a popliteal plexus block with either 10 mL or 20 mL of bupivacaine 5 mg/mL, in addition to a standardized multimodal analgesic regimen including a femoral triangle block. The primary outcome was 24-hour postoperative opioid consumption. Secondary outcomes included the proportion of patients achieving opioid-free analgesia, pain scores, early functional outcomes and patient-reported Quality of Recovery-15. RESULTS: No statistically significant or clinically relevant differences were observed between the two groups in 24-hour postoperative opioid consumption (median 15 (IQR 3.75-30) vs 15 mg (IQR 0-30) oral morphine milligram equivalents; median difference 0 mg, 95% CI -10 to 5; p=0.6), the proportion of patients achieving opioid-free analgesia, pain at rest or during ambulation, ability to ambulate with crutches, motor impairment, or patient-reported quality of recovery. CONCLUSIONS: Use of 20 mL of local anesthetic for the popliteal plexus block as part of a multimodal analgesic regimen after total knee arthroplasty does not provide superior analgesic efficacy or improved functional outcomes compared with 10 mL. Consistent with the principle of using the lowest effective dose and minimizing cumulative local anesthetic exposure, these findings support the use of 10 mL of local anesthetic for popliteal plexus block in clinical practice and in future research. TRIAL REGISTRATION NUMBER: EUCT number: 2024-520204-26-00.

来源:Reg Anesth Pain Med,查看原文。版权归原作者所有。

引用

  1. Sørensen JK, Jensen MSH, Grevstad U, et al. Analgesic efficacy and functional outcomes of 10 versus 20 mL bupivacaine for popliteal plexus block after total knee arthroplasty: a randomized clinical trial. Reg Anesth Pain Med. 2026. PMID: 41850708. doi:10.1136/rapm-2026-107696

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。